Susan Collins actually said...
Our bill is the product of consultations with a wide range of stakeholders, as Senator Feinstein has mentioned, and it would give the FDA broader oversight.
Context
Collins emphasizes stakeholder involvement in creating the bill for FDA oversight.
09/21/2016